최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기기본간호학회지 = Journal of Korean Academy of Fundamentals of Nursing, v.25 no.3, 2018년, pp.176 - 184
김혜미 (국립암센터 간호사.이화여자대학교 임상보건융합대학원) , 박효정 (이화여자대학교 간호대학.이화간호과학연구소)
Purpose: Purpose of this study was to investigate relationships and influence of peripheral neuropathy, sleep, and quality of life in patients with gastric cancer who are receiving chemotherapy. Methods: Participants were 131 patients with gastric cancer being treated at a chemotherapy outpatient cl...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
항암화학요법의 부작용은 무엇인가? | 또한 수술 후에도 TNM (종양의 크기, 림프절 전이, 원격전이 여부) 분류에 따라 병기가 2~3기이면 재발을 막기 위해 일시적(6개월~1년)으로 보조적 항암화학요법을 시행한다[2]. 항암화학요법은 암의 진행속도 감소, 생존율 증가 및 삶의 질 향상을 위한 암 치료의 주된 방법이지만 오심, 구토, 변비, 설사, 골수기능저하, 구내염, 피로, 수면장애, 우울, 말초신경병증 등 전신적인 부작용이 발생한다[3]. 이들 부작용 중 말초신경병증을 유발하는 신경독성 항암제는 Platinum compounds (Oxaliplatin, Cisplatin, Carboplatin), Taxanes (Docetaxel, Paclitaxel), Vinca alkaloids(Vincristine), Bortezomib, Thalidomide 등이 있으며[4] 위 약제들은 위암 환자의 주요 항암화학요법 치료에 사용되는 약제이며 위암에서 Cisplatin을 사용하였을 경우 64%의 말초신경병증이 발생하였음을 보고하였다[2]. | |
위암 치료의 종류에는 어떠한 것이 있는가? | 위암 치료는 위암의 진행 정도에 따라 결정되고, 내시경 절제술, 수술 및 항암화학요법, 방사선요법 등이 있다. 현재 위암의 가장 기본적인 치료방법은 수술이지만 다른 장기나 림프절로 전이된 경우에는 항암화학요법을 시행한다. | |
말초신경병증은 항암제의 누적 용량과 어떠한 상관 관계를 가지는가? | 본 연구의 결과, 통증이 있거나 신경독성 항암제 개수가 3개 이상일 때 말초신경병증, 수면, 삶의 질 모두에서 차이를 보였고 말초신경병증과 수면, 수면과 삶의 질에 유의한 상관성이 있었다. 대상자의 삶의 질에 영향을 미치는 주요 요인은 수면이었다. |
National Cancer Information Center. Statistics of cancer [Internet]. Gyeonggido: National Cancer Information Center; 2016 [cited 2017 November 15]. Available from: https://www.cancer.go.kr/lay1/S1T639C641/contents.do
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461-2470. https://doi.org/ 10.1016/j.pain.2014.09.020
Hong JS, Tian J, Wu LH. The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Current Oncology. 2014;21(4):174-180. https://doi.org/10.3747/co.21.1984
Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. Journal of Clinical Oncology. 2014;32(18):1941-1967. https://doi.org/10.1200/JCO.2013.54.0914
Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: Results from the population-based profiles registry. Journal of Clinical Oncology. 2013;31(21):2699-2707. https://doi.org/10.1200/JCO.2013.49.1514
Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, et al. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the eastern cooperative oncology group symptom outcomes and practice patterns study. Cancer. 2013;119(24):4333-4340. https://doi.org/10.1002/cncr.28376
Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors. Supportive Care in Cancer. 2013;21(12):3307-3313. https://doi.org/10.1007/s00520-013-1905-5
Innominato PF, Spiegel D, Ulusakarya A, Giacchetti S, Bjarnason GA, Levi F, et al. Subjective sleep and overall survival in chemotherapy-naive patients with metastatic colorectal cancer. Sleep Medicine. 2015;16(3):391-398. https://doi.org/10.1016/j.sleep.2014.10.022
Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biological Psychiatry. 2016;80(1):40-52. https://doi.org/10.1016/j.biopsych.2015.05.014
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359-E386. https://doi.org/10.1002/ijc.29210
Shin DW, Sunwoo S, Lee JK. Management of cancer survivors in Korea. Journal of the Korean Medical Association. 2015;58(3):216-226. https://doi.org/10.5124/jkma.2015.58.3.216
Tofthagen C, McAllister RD, Visovsky C. Peripheral neuropathy caused by paclitaxel and docetaxel: An evaluation and comparison of symptoms. Journal of the Practitioner in Oncology. 2013;4(4):204-215.
Health Insurance Review & Assessment Service. Evaluate the appropriateness of its stomach cancer. [Internet]. Gangwondo: Health Insurance Review & Assessment Service; 2017 [cited 2017 November 13]. Available from: https://www.hira.or.kr/dummy.do
Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer. 2005;41(8):1135-1139. https://doi.org/10.1016/j.ejca.2005.02.012
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research. 1989;28(2):193-213.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy (FACT) scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993;11(3):570-579. https://doi.org/10.1200/JCO.1993.11.3.570
Kim HM. Symptoms related to chemotherapy induced peripheral neuropathy. [master's thesis]. Daegu: Keimyung University; 2012. p. 1-34.
Nishiura M, Tamura A, Nagai H, Matsushima E. Assessment of sleep disturbance in lung cancer patients: Relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress. Palliative and Supportive Care. 2015;13(3):575-581. https://doi.org/10.1017/S1478951513001119
Hallworth P, Simpson S, Bennett B, Byrne K, Rider A, Desai T, et al. PCN243-are there differences in Fact-G scores between different tumour types for an EU population using real world data?. Value in Health. 2017;20(9):A456. https://doi.org/10.1016/j.jval.2017.08.325
Seo JY, Yi M. Distress and quality of life in cancer patients receiving chemotherapy. Asian Oncology Nursing. 2015;15(1):18-27. https://doi.org/10.5388/aon.2015.15.1.18
Yu R, Deochand C, Krotow A, Leao R, Tong M, Agarwal AR, et al. Tobacco smoke-induced brain white matter myelin dysfunction: Potential co-factor role of smoking in neurodegeneration. Journal of Alzheimer's Disease. 2016;50(1):133-148. https://doi.org/10.3233/JAD-150751
Oh SY, Shin SW, Koh SJ, Bae SB, Chang H, Kim JH, et al. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients. Supportive Care in Cancer. 2017;25(12):3759-3767. https://doi.org/10.1007/s00520-017-3806-5
Lee JS, Jeong DU. Sleep and pain. Sleep Medicine and Psychophysiology. 2012;19(2):63-67.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.